Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-PSMA-11 PET in Patients With Prostate Cancer
NCT04777071Phase 2Active, not recruiting
- Sponsor
- University of Washington
- Start
- May 2021
- Primary completion
- Jul 2025
- Modality
- Peptide-Drug Conjugates
- Countries
- 1
01
Overview
A Phase 2 trial of gallium ga-68 gozetotide in prostate cancer (PCa), sponsored by University of Washington. Started May 2021; status: active, not recruiting.
02
Drugs
gallium ga-68 gozetotide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT04777071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04777071.